Page last updated: 2024-08-24

cisatracurium and Intraventricular Septal Defects

cisatracurium has been researched along with Intraventricular Septal Defects in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, C; Peng, X; Wang, S; Wu, B; Wu, Z; Ye, X1
Russo, P; Tobias, JD; Torres, J1

Trials

1 trial(s) available for cisatracurium and Intraventricular Septal Defects

ArticleYear
Altered Cisatracurium Pharmacokinetics and Pharmacodynamics in Patients with Congenital Heart Defects.
    Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:1

    Topics: Adult; Atracurium; Female; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neuromuscular Blocking Agents; Neuromuscular Junction; Neuromuscular Monitoring; Tissue Distribution; Young Adult

2016

Other Studies

1 other study(ies) available for cisatracurium and Intraventricular Septal Defects

ArticleYear
Anaesthetic implications of LEOPARD syndrome.
    Paediatric anaesthesia, 2004, Volume: 14, Issue:4

    Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Atracurium; Cardiopulmonary Bypass; Child, Preschool; Fentanyl; Heart Septal Defects, Ventricular; Humans; LEOPARD Syndrome; Male; Methyl Ethers; Neuromuscular Blocking Agents; Perioperative Care; Pulmonary Valve; Pulmonary Valve Stenosis; Sevoflurane

2004